These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30275766)

  • 1. The Relationship between Follicle-stimulating Hormone and Bone Health: Alternative Explanation for Bone Loss beyond Oestrogen?
    Chin KY
    Int J Med Sci; 2018; 15(12):1373-1383. PubMed ID: 30275766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone metabolism by sex hormones and gonadotropins].
    Imai Y
    Clin Calcium; 2014 Jun; 24(6):815-9. PubMed ID: 24870831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation.
    Wang J; Zhang W; Yu C; Zhang X; Zhang H; Guan Q; Zhao J; Xu J
    PLoS One; 2015; 10(8):e0134986. PubMed ID: 26241313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FSH directly regulates bone mass.
    Sun L; Peng Y; Sharrow AC; Iqbal J; Zhang Z; Papachristou DJ; Zaidi S; Zhu LL; Yaroslavskiy BB; Zhou H; Zallone A; Sairam MR; Kumar TR; Bo W; Braun J; Cardoso-Landa L; Schaffler MB; Moonga BS; Blair HC; Zaidi M
    Cell; 2006 Apr; 125(2):247-60. PubMed ID: 16630814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation.
    Iqbal J; Sun L; Kumar TR; Blair HC; Zaidi M
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14925-30. PubMed ID: 17003115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicle-stimulating hormone does not impact male bone mass in vivo or human male osteoclasts in vitro.
    Ritter V; Thuering B; Saint Mezard P; Luong-Nguyen NH; Seltenmeyer Y; Junker U; Fournier B; Susa M; Morvan F
    Calcif Tissue Int; 2008 May; 82(5):383-91. PubMed ID: 18465073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FSH versus estrogen: who's guilty of breaking bones?
    Baron R
    Cell Metab; 2006 May; 3(5):302-5. PubMed ID: 16679287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition.
    Zaidi M; Blair HC; Iqbal J; Davies TF; Zhu LL; Zallone A; Sun L
    Curr Rheumatol Rep; 2009 Jul; 11(3):191-5. PubMed ID: 19604463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking FSH action attenuates osteoclastogenesis.
    Zhu LL; Tourkova I; Yuen T; Robinson LJ; Bian Z; Zaidi M; Blair HC
    Biochem Biophys Res Commun; 2012 May; 422(1):54-8. PubMed ID: 22561017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis.
    Zhu LL; Blair H; Cao J; Yuen T; Latif R; Guo L; Tourkova IL; Li J; Davies TF; Sun L; Bian Z; Rosen C; Zallone A; New MI; Zaidi M
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14574-9. PubMed ID: 22908268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological estrogen administration causes a FSH-independent osteo-anabolic effect requiring ER alpha in osteoblasts.
    Seitz S; Keller J; Schilling AF; Jeschke A; Marshall RP; Stride BD; Wintermantel T; Beil FT; Amling M; Schütz G; Tuckermann J; Schinke T
    PLoS One; 2012; 7(11):e50301. PubMed ID: 23209701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone and calcium metabolism in menopause transition].
    Terauchi M
    Clin Calcium; 2011 Sep; 21(9):1353-9. PubMed ID: 21881198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An activated human follicle-stimulating hormone (FSH) receptor stimulates FSH-like activity in gonadotropin-deficient transgenic mice.
    Haywood M; Tymchenko N; Spaliviero J; Koch A; Jimenez M; Gromoll J; Simoni M; Nordhoff V; Handelsman DJ; Allan CM
    Mol Endocrinol; 2002 Nov; 16(11):2582-91. PubMed ID: 12403847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis.
    Qian H; Guan X; Bian Z
    Mol Med Rep; 2016 Oct; 14(4):2997-3006. PubMed ID: 27510616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extragonadal Effects of Follicle-Stimulating Hormone on Osteoporosis and Cardiovascular Disease in Women during Menopausal Transition.
    Zhu D; Li X; Macrae VE; Simoncini T; Fu X
    Trends Endocrinol Metab; 2018 Aug; 29(8):571-580. PubMed ID: 29983231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proresorptive actions of FSH and bone loss.
    Zaidi M; Blair HC; Iqbal J; Zhu LL; Kumar TR; Zallone A; Sun L
    Ann N Y Acad Sci; 2007 Nov; 1116():376-82. PubMed ID: 18083939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence for direct pro-resorptive actions of FSH.
    Sun L; Zhang Z; Zhu LL; Peng Y; Liu X; Li J; Agrawal M; Robinson LJ; Iqbal J; Blair HC; Zaidi M
    Biochem Biophys Res Commun; 2010 Mar; 394(1):6-11. PubMed ID: 20171951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with FSHβ fusion protein antigen prevents bone loss in a rat ovariectomy-induced osteoporosis model.
    Geng W; Yan X; Du H; Cui J; Li L; Chen F
    Biochem Biophys Res Commun; 2013 May; 434(2):280-6. PubMed ID: 23537645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal osteoporosis: the role of immune system cells.
    Faienza MF; Ventura A; Marzano F; Cavallo L
    Clin Dev Immunol; 2013; 2013():575936. PubMed ID: 23762093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.